Ogawa Kazuhiko, Nakamura Katsumasa, Onishi Hiroshi, Koizumi Masahiko, Sasaki Tomonari, Araya Masayuki, Miyabe Yuuki, Otani Yuuki, Teshima Teruki
Department of Radiology, University of the Ryukyus, Okinawa, Japan.
Anticancer Res. 2006 Mar-Apr;26(2B):1319-25.
The influence of age on the patterns and outcomes of external beam radiotherapy for clinically localized prostate cancer patients was examined.
The Japanese Patterns of Care Study surveys were used to compare the processes and outcomes of radical external beam radiotherapy in 140 elderly patients (>75 years old) and 304 younger patients (<75 years old).
Although the Karnofsky performance status was significantly different between elderly and younger patients, there were no significant differences in disease characteristics such as pretreatment PSA level, differentiation, Gleason combined score and clinical T stage. There were also no significant differences in the treatment characteristics such as CT-based treatment planning, conformal therapy, total radiation doses (both a median of 66.0 Gy) and hormonal therapy usage. Moreover, no significant differences in overall survival, biochemical relapse-free survival and late toxicity rates were observed between elderly and younger patients.
Age did not influence the disease characteristics, patterns of external beam radiotherapy, survival and late toxicities for clinically localized prostate cancer patients. Therefore, radiotherapy could represent an important treatment modality for elderly patients as well as for younger ones.
研究了年龄对临床局限性前列腺癌患者体外放疗模式及结果的影响。
采用日本癌症治疗模式研究调查,比较140例老年患者(>75岁)和304例年轻患者(<75岁)接受根治性体外放疗的过程及结果。
尽管老年患者和年轻患者的卡氏功能状态存在显著差异,但在疾病特征如治疗前前列腺特异抗原(PSA)水平、分化程度、 Gleason综合评分和临床T分期方面无显著差异。在治疗特征如基于CT的治疗计划、适形放疗、总辐射剂量(两者中位数均为66.0 Gy)和激素治疗使用方面也无显著差异。此外,老年患者和年轻患者在总生存、生化无复发生存和晚期毒性率方面未观察到显著差异。
年龄对临床局限性前列腺癌患者的疾病特征、体外放疗模式、生存及晚期毒性无影响。因此,放疗对老年患者和年轻患者而言都是一种重要的治疗方式。